MAPT and early-onset autosomal dominant Alzheimer disease: A clinical study was conducted to evaluate Aβ, tau, and KYN in the CSF, as well as KYN, L-TRP, and 5-HT in serum, in patients with normal cognition, MCI, and Alzheimer’s disease.